✦ LIBER ✦

PCN7 ANALYSIS AND CATEGORISATION OF DRUG-RELATED PROBLEMS ASSOCIATED WITH SYSTEMIC BREAST CANCER THERAPY

✍ Scribed by N Reineking; A Glasmacher; M Kühr; M Braun; W Kuhn; U Jaehde

Book ID: 119597396
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 71 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)66545-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJU

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH TRASTUZUMAB FOR HER2-POSITIVE EARLY BREAST CANCER IN POLISH SETTING

✍ E Orlewska; T Pienkowski; K Drosik; M Gyldmark; R Aultman; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Reduced rates of cancer-related worries

Reduced rates of cancer-related worries and mortality associated with guideline surveillance after breast cancer therapy

✍ Timothy L. Lash; Kerri Clough-Gorr; Rebecca A. Silliman 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 109 KB

Polymorphisms in genes of the steroid re

Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy

✍ The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone The 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 183 KB 👁 1 views

## Abstract Menopausal hormone therapy (HT) is associated with increased breast cancer risk among postmenopausal women. Nuclear receptors are involved in steroid hormone‐ and xenobiotic‐mediated signal transduction playing a crucial role in regulating gene expression. Therefore, variations within t

Dosimetric Analysis of Cardiac Substruct

Dosimetric Analysis of Cardiac Substructure Related to Cardiac Safety in Patients With HER2-Positive Breast Cancer Receiving Concurrent Trastuzumab and Adjuvant Radiation Therapy

✍ Chen, J.; Cao, L.; Yang, Z. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Postmastectomy Radiation and Adjuvant Sy

Postmastectomy Radiation and Adjuvant Systemic Therapy: Outcomes in High-Risk Women with Stage II–III Breast Cancer and Assessment of Clinical, Pathologic, and Treatment-Related Factors Influencing Local-Regional Control

✍ Gary M. Freedman; Barbara L. Fowble; Alexandra L. Hanlon; Douglas A. Fein; John 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 789 KB

A phase II study of lapatinib for brain

A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients

✍ Iwata, Hiroji; Narabayashi, Masaru; Ito, Yoshinori; Saji, Shigehira; Fujiwara, Y 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 288 KB